selected publications
-
article
-
Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: Comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study.
Annals of the Rheumatic Diseases.
76:355-363.
2017-01-01
-
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.
Annals of the Rheumatic Diseases.
76:346-354.
2017-01-01
-
Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: Comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study.
Annals of the Rheumatic Diseases.
76:355-363.
2017-01-01